Skip to main content

Table 2 Review progress and workload implications during the pilot period

From: Feasibility and acceptability of living systematic reviews: results from a mixed-methods evaluation

Review topica

Anti-coagulation in people with cancer (3 related LSRs)b

Fruit and vegetable consumption in children

Delayed antibiotics for respiratory infections

Zika virus and adverse neurological outcomes

Adherence to guidelines in traumatic brain injury

Epidemiology of traumatic brain injury

Date ‘baseline’ review published

LSR 1c: September 2017

LSR 2d: December 2017

LSR 3e: June 2018

September 2017

September 2017

February 2018

October 2015

November 2015

No. of studies in ‘baseline’ publication

LSR 1c: 19

LSR 2d: 7

LSR 3e: 16

50

11

101

22

66

No. of new studies found since ‘baseline’ publicationf

5g

13

0

96

14

18

No. of status updates since baseline review

Monthly updates

LSR 1c: 10

LSR 2d: 7

LSR 3e: 1

10

10

0

4

3

No. of times review re-published

07

2 (January and May 2018)

0

0

0

0

  1. No. number
  2. aEach team produced one LSR unless otherwise stated
  3. bThese three LSRs were part of a suite of LSRs that used a single search
  4. cRefers to the first in the suite of LSRs published: Parenteral anticoagulation in ambulatory patients with cancer.
  5. dRefers to the second in the suite of LSRs published: Oral anticoagulation in people with cancer who have no therapeutic or prophylactic indication for anticoagulation.
  6. eRefers to the third in the suite of LSRs published: Anticoagulation for the long-term treatment of venous thromboembolism in people with cancer.
  7. fIncludes new (not ongoing) studies that were screened and found to meet the inclusion criteria for the review until the end of the pilot period
  8. gData presented for all three reviews (as appropriate, given they transitioned into living mode at different times during the pilot period) given the same search fed into all reviews and they were managed by the same author and editorial teams